| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.13B | +13.1% |
| Cost of Revenue | $1.69B | +24.3% |
| Gross Profit | $1.44B | +2.3% |
| R&D Expense | $788.9M | +70.9% |
| SG&A Expense | $344.7M | +34.5% |
| Operating Income | -$530.9M | -325.8% |
| Pre-tax Income | -$492.3M | -308.1% |
| Income Tax | $5.7M | +198.7% |
| Net Income | -$498.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.96B | -8.6% |
| Accounts Receivable | $760.8M | +1.1% |
| Inventory | $106.7M | +112.3% |
| Current Assets | $2.96B | -2.9% |
| Total Assets | $4.41B | +8.1% |
| Current Liabilities | $1.08B | +48.5% |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $11.8M | -94.8% |
| Capital Expenditures | $161.7M | +303.8% |
| Investing Cash Flow | -$201.7M | -14.1% |
| Financing Cash Flow | $8.4M | -99.2% |
| Free Cash Flow | -$149.9M | -179.7% |
| -305.5% |
| EPS (Basic) | -$3.62 | -297.8% |
| EPS (Diluted) | -$3.62 | -311.7% |
| Total Liabilities |
| $1.77B |
| +34.2% |
| Stockholders' Equity | $2.65B | -4.3% |